Bill Dollard

Bill Dollard

Employee since 2002
Technical Operations

Therapies developed on a foundation of experience

We have a deep understanding of - and experience in - nervous system research, product development and commercialization. This expertise enables us to focus on therapies that have a potential to improve the lives of people with neurological disorders. In this section you can learn more about AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg as well as medications that we are studying to treat a range of neurological disorders.

Product Pipeline

We’re dedicated to the development and commercialization of novel therapies to improve, repair and restore neurological function in people with a range of nervous system disorders, including Parkinson’s disease, epilepsy, stroke, migraine and multiple sclerosis.